Capabilities
Real-World Data & Analytics
Real-World Data (RWD) comes from sources
such as Electronic Health Records (EHR) systems, medical claims, and registries,
providing clinical evidence on the usage and potential benefits or risks of drugs
and medical devices. Our expert team helps clients ensure data quality, generate
valuable evidence, and improve patient outcomes.
Artificial Intelligence
In the 2020s, AI saw
unprecedented growth, driven by powerful hardware, vast data sets, and
innovative algorithms. At Polygon Health Analytics, we believe successful AI
implementation relies on a balanced approach, emphasizing the right business
niche and effective change management, rather than just advanced algorithms,
to deliver impact.
Health Economics & Outcome Research
Health Economics and Outcomes Research
(HEOR) plays a vital role in demonstrating the value of new interventions (e.g.,
drugs) by assessing real-world outcomes, financial impacts, and quality of life.
This enables evidence-based decisions and improved outcomes for all
stakeholders.
Market Access & Reimbursement
The U.S., accounting for one-third of the $1.48 trillion
global healthcare market, is undergoing significant policy shifts, including the
Inflation Reduction Act and Pharmacy Benefit Manager (PBM) reforms. We help
biopharmaceutical and medical device companies navigate these changes and
optimize their market access and reimbursement strategies.
